头颈癌放疗后90天死亡率:城乡患者基于人群的比较
本研究纳入1998至2014年在不列颠哥伦比亚省接受放疗的全部头颈癌患者,按Modified Statistics Canada定义分为农村与城市组,比较放疗后90天死亡率。农村与城市患者90天死亡率分别为3.0%与3.9%(p=0.09),单因素与多因素分析均未显示农村性与90天死亡率相关。
要点
- 农村与城市头颈癌放疗患者90天死亡率分别为3.0%与3.9%,差异无统计学意义(p=0.09)。
- 单因素和多因素分析均未发现农村性与90天死亡率存在关联。
- 研究提示在控制潜在混杂因素后,农村居住未显著增加放疗后90天死亡风险。
核心结论
- 在控制潜在混杂因素后,不列颠哥伦比亚省接受放疗的头颈癌患者中,农村性与90天死亡率无显著关联。
主要发现
- 农村患者90天死亡率为3.0%,城市患者为3.9%(p=0.09)。
- 单因素和多因素分析均未显示农村性与90天死亡率存在关联。
关键数值与推荐
- 农村与城市患者90天死亡率分别为3.0%与3.9%,组间比较p=0.09。
临床怎么用
- 对于接受放疗的头颈癌患者,农村居住本身不应被视为90天死亡风险增高的独立因素。
- 临床决策中可结合其他混杂因素综合评估放疗后早期死亡风险,而非仅依据城乡居住地。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study assesses whether 90-day mortality differs between patients living in rural and urban areas, as lower access to supportive care services in rural areas could result in higher mortality. METHODS: All patients with head and neck cancer (HNC) treated between 1998 and 2014 with radiotherapy in British Columbia were included. Patients were divided into rurality areas according to the Modified Statistics Canada (mSC) definition, which classifies a population <30 000 as rural and ≥30 000 as urban. RESULTS: Five thousand five hundred and fifty-four patients were included in this study, of which 68% lived in urban centers. The 90-day mortality for rural versus urban patients were 3.0% and 3.9% (p = 0.09), respectively. Univariate and multivariate analyses showed no association with 90-day mortality and rurality. CONCLUSION: After controlling for potentially confounding factors, we did not find a significant association between 90-day mortality and rurality in patients who were treated with radiotherapy for HNC in British Columbia.
引用
- Schlijper R, Bos S, Hamilton SN, et al. Ninety-day mortality after radiotherapy for head and neck cancer: Population-based comparison between rural and urban patients. Head Neck. 2021. PMID: 34288200. doi:10.1002/hed.26819
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。